Migraine. Migraine
Conditions
Interventions
Intervention 1: Intervention group: Patients with migraine receiving ?lavender tablet 500 mg three times a day for two months along with common treatments (Nortriptyline and propranolol). Intervention
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with Migraine Age between 20 to 60
Exclusion criteria
Exclusion criteria: Suffering from chronic diseases Suffering from diseases associated with weak immune system Using lavender products or unknown drugs in the last three months Abuse of drugs and substances History of seizures and head trauma Pregnant and lactating mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in pain intensity in migraine attacks. Timepoint: Every migraine attack. Method of measurement: VAS pain questionnaire.;Change in numbers of migraine attacks. Timepoint: Every migraine attack. Method of measurement: Checklist.;Change in pain duration in each migraine attack. Timepoint: Every migraine attack. Method of measurement: Checklist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the impact of headache complications on quality of life. Timepoint: In every migraine attack. Method of measurement: HIT-6 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVahid Reza Askari
Mashhad University of Medical Sciences
Outcome results
None listed